Clinical Trials Browser

Adenocarcinoma Of Esophagus, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Colitis, Ulcerative, Colonic Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Melanoma

NCT05961709 2025-10-24

The Phoenix Trial: Phase II Trial of Cemiplimab for the Non-operative Management of Localized dMMR Colon Cancer

Phase 2 Recruiting

50 enrolled

Gastrointestinal

Colonic Neoplasms

NCT07140679 2025-09-25

Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer

Phase 2 Recruiting

40 enrolled

Gastrointestinal

Colonic Neoplasms

NCT06368141 2025-09-24

NeoCHIC

Phase 2 Recruiting

56 enrolled

Gastrointestinal

Colonic Neoplasms

NCT07085169 2025-07-25

Low-dose Trifluridine/Tipiracil With Bevacizumab in mCRC

Phase 2 Recruiting

50 enrolled

Gastrointestinal

Colonic Neoplasms

NCT06949111 2025-07-01

Radiotherapy + Systemic Therapy as Conversion Therapy for pMMR/MSS T4M0 Colon Cancer（Neo-Color）

Phase 2 Recruiting

128 enrolled

Gastrointestinal

Colonic Neoplasms

NCT03175224 2025-06-27

SPARTA

Phase 2 Recruiting

497 enrolled

CNSGastrointestinalGenitourinaryHead & NeckThoracic

Brain Neoplasms, Colonic Neoplasms, Glioblastoma, Kidney Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Thyroid Neoplasms

NCT07003022 2025-06-04

Phase Ⅱ Clinical Trial of Cadonilimab Combined With Anti-angiogenic Agents in Metastatic dMMR/MSI-H CRC

Phase 2 Recruiting

40 enrolled

Gastrointestinal

Colonic Neoplasms

NCT05239546 2025-05-25

NAIO

Phase 2 Recruiting

25 enrolled

Gastrointestinal

Colonic Neoplasms

NCT05870800 2025-05-25

NICER

Phase 2 Recruiting

28 enrolled

Gastrointestinal

Colonic Neoplasms

NCT04291105 2025-03-26

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

Phase 2 Recruiting

87 enrolled

DermatologicGastrointestinalHead & Neck

Squamous Cell Carcinoma of Head and Neck, Colonic Neoplasms, Melanoma

NCT06640166 2025-02-12

ECLYPse

Phase 2 Recruiting

25 enrolled

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT06643793 2025-01-28

Evaluation of Irinotecan Liposome (II) Combined With 5-FU, LV, and Bevacizumab for mCRC

Phase 2 Recruiting

30 enrolled

Gastrointestinal

Colonic Neoplasms

NCT06425133 2024-12-24

CARE

Phase 2 Recruiting

174 enrolled

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT04920149 2024-12-17

MesaCAPP

Phase 2 Recruiting

150 enrolled

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis

NCT06242418 2024-12-12

REVISE

Phase 2 Recruiting

60 enrolled

Gastrointestinal

Colonic Neoplasms

NCT06580574 2024-08-30

Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers

Phase 2 Recruiting

38 enrolled

Gastrointestinal

Colonic Neoplasms, Stomach Neoplasms

NCT06575127 2024-08-28

Modified FOLFOXIRI Plus Target Therapy as a First Line Treatment for Advanced Colorectal Cancer a Prospective Phase Two Study

Phase 2 Recruiting

60 enrolled

Gastrointestinal

Colonic Neoplasms, Neoplasms

NCT05197322 2024-08-05

NEOPRISM-CRC

Phase 2 Recruiting

78 enrolled

Gastrointestinal

Colonic Neoplasms

NCT06436976 2024-05-31

The Effect of Probiotics ATG-F4 in Cancer Patients

Phase 2 Recruiting

30 enrolled

Gastrointestinal

Colonic Neoplasms, Pancreatic Neoplasms

NCT06014372 2024-04-12

Envafolimab Monotherapy or Envafolimab + CAPEOX as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer

Phase 2 Recruiting

55 enrolled

Gastrointestinal

Colonic Neoplasms

NCT06017141 2023-08-30

Inhalational or Intravenous Anesthesia During Surgery for Patients With Colon Cancer, VIVA Study

Phase 2 Recruiting

80 enrolled

Gastrointestinal

Colonic Neoplasms

NCT03280511 2022-10-06

Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer Patients

Phase 2 Recruiting

60 enrolled

GastrointestinalGynecologic

Colonic Neoplasms, Peritoneal Neoplasms

Clinical Trials

SCOTI

AZUR-4

TRIUNITE-08

PILDI

NICHE

Phase II Trial of Lung Chemoemobolization

Superhero

PILDI

Microbiotic Product to Promote Microbiome Health and Improve Chemotherapy Delivery

MODIFI-L

Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors

PSI-Immune

The Phoenix Trial: Phase II Trial of Cemiplimab for the Non-operative Management of Localized dMMR Colon Cancer

Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer

NeoCHIC

Low-dose Trifluridine/Tipiracil With Bevacizumab in mCRC

Radiotherapy + Systemic Therapy as Conversion Therapy for pMMR/MSS T4M0 Colon Cancer（Neo-Color）

SPARTA

Phase Ⅱ Clinical Trial of Cadonilimab Combined With Anti-angiogenic Agents in Metastatic dMMR/MSI-H CRC

NAIO

NICER

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

ECLYPse

Evaluation of Irinotecan Liposome (II) Combined With 5-FU, LV, and Bevacizumab for mCRC

CARE

MesaCAPP

REVISE

Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers

Modified FOLFOXIRI Plus Target Therapy as a First Line Treatment for Advanced Colorectal Cancer a Prospective Phase Two Study

NEOPRISM-CRC

The Effect of Probiotics ATG-F4 in Cancer Patients

Envafolimab Monotherapy or Envafolimab + CAPEOX as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer

Inhalational or Intravenous Anesthesia During Surgery for Patients With Colon Cancer, VIVA Study

Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer Patients